Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)

Authors:
  • RCRobert M. Califf
    Robert M. Califf
  • FAFrank V. Aguirre
    Frank V. Aguirre
  • KAKeaven Anderson
    Keaven Anderson
  • KSKristina N. Sigmon
    Kristina N. Sigmon
  • HWHarlan F. Weisman
    Harlan F. Weisman
  • TIThe EPIC Study Investigators
    The EPIC Study Investigators

Abstract
No abstract available

This publication has 20 references indexed in Scilit: